Hyperprolactinemia may be induced through dopamine antagonism (antipsychotics) or serotonin stimulation (clomipramine), while LHRH agonists have been documented to compensate the hyperprolactinemia present in microprolactinomas [64,65]. The gene discussed is GNRH1; the disease is hyperprolactinemia.